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Background: The aim of this study is to compare the diagnostic performance of the line probe assay (LPA) with
conventional multiplex polymerase chain reaction (PCR) for Streptococcus pneumoniae as well as real-time PCR for
Neisseria meningitidis and Haemophilus influenzae type b (Hib) in cerebrospinal fluid (CSF) samples from children
during the multicenter national surveillance of bacterial meningitis between the years 2006 and 2009 in Turkey.
Results: During the study period 1460 subjects were enrolled and among them 841 (57%) met the criteria for
probable bacterial meningitis. The mean age of subjects was 51 ± 47 months (range, 1–212 months). We performed
the line probe assay in 751 (89%) CSF samples of 841 probable bacterial meningitis cases, of whom 431 (57%) were
negative, 127 (17%) were positive for S. pneumoniae, 53 (7%) were positive for H. influenzae type b, and 41 (5%)
were positive for N. meningitidis. The LPA was positive in 19 of 23 (82%) S. pneumoniae samples, 4 of 6 (67%) N.
meningitidis samples and 2 of 2 (100%) Hib samples in CSF culture-positive cases. The specificity of the LPA for all of
S. pneumoniae, H. influenzae type b, and N. meningitidis was 88% (95% CI: 85–91%), when using the standard PCR as
a reference. The specificity of LPA for each of S. pneumoniae, H. influenzae type b, and N. meningitidis was 93% (95%
CI: 89–95%), 96% (95% CI: 94–98%), and 99% (95% CI: 97–99%), respectively. For all of S. pneumoniae, H. influenzae type
b and N. meningitidis the sensitivity of the LPA was 76% (95% CI: 70–82%) and for each of S. pneumoniae, H.
influenzae type b and N. meningitidis was 72% (95% CI:63–79%), 88% (95% CI: 73–95%), and 81% (95% CI:67–
92%), respectively.
Conclusions: The LPA assay can be used to detect common bacterial meningitis pathogens in CSF samples,
but the assay requires further improvement.
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National surveillances of bacterial meningitis can help
identify the country-specific etiological agents and
their serogroups/serotypes thus it can be provided in-
formation for implementation of vaccines in national
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growth of bacteria in cerebrospinal fluid (CSF) cul-
ture. However, the unavailability of a microbiology la-
boratory, lack of quality control for media, suboptimal
transport conditions or delays of the CSF samples
and receiving oral or parenteral antibiotic treatment
prior to lumbar puncture (L/P) can lead to low rates
of CSF culture positivity. CSF culture positivity may
be as low as 67 and 56% in patients who have received
prior oral and parenteral antibiotics, respectively [1]. Be-
cause of these problems it may result in an underestima-
tion of the disease burden and the potential impact ofle is distributed under the terms of the Creative Commons Attribution 4.0
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culture based method, is an alternative approach for both
the diagnosis and surveillance of bacterial meningitis
with has high sensitivity and specificity. Currently,
many experts have accepted either PCR or culture as
the gold standard methods in developed and develop-
ing countries [2–5].
We have recently designed a line probe assay
(LPA) [based on multiplex PCR followed by reverse
hybridization using sequence-specific oligonucleotide
probes (SSOP)] for the rapid detection of the major
bacterial pathogens and their serotypes/serogroups
that cause meningitis. Herein, we compare the diag-
nostic performance of the LPA with conventional
multiplex PCR for Streptococcus pneumoniae as well as
real-time PCR for Neisseria meningitidis and Haemophilus
influenzae type b in CSF samples which were taken from
children during the multicenter national surveillance of
bacterial meningitis between the years 2006 and 2009 in
Turkey.
Methods
A prospective surveillance was performed in collabor-
ation with the Department of Infectious Diseases,
Ministry of Health between July 2006 and January
2009. A total of 37 hospitals located in 23 cities
(representing 59% of the whole population of the
country) across seven geographic regions participated.
Ethical approval for the study was obtained from the
ethical committee of the Marmara University School
of Medicine. Written informed consent was obtained
from the caregiver of each enrolled child. The surveil-
lance study included children <18 years of age (excluding
newborns) who were admitted to an emergency room
and underwent lumbar puncture for suspected menin-
gitis (based on signs and symptoms of meningitis, in-
cluding fever, vomiting, headache, seizure, meningeal
irritation, and impaired consciousness) and who met
any of the following CSF laboratory criteria: [1] turbid
CSF; [2] >99 leukocytes/mm3 in CSF; or [3] 10–99
leukocytes/mm3 in CSF with low CSF glucose
(<40 mg/dL) and high CSF protein (>99 mg/dL) and
no more than a few red blood cells in each mm3 of
CSF [5]. The collected CSF specimens for PCR studies
were stored at −20 °C until transported under cold-chain
conditions to the Marmara University Hospital, Pediatric
Infectious Diseases Research Laboratory. The samples
were then stored at −80 °C until they were sent to the
Streptococcus and Meningococcus Laboratories of the U.S.
Centers for Diseases Control and Prevention, Atlanta for
standard PCR analysis [6, 7]. The line probe assay was
performed at the Marmara University Hospital Pediatric
Infectious Diseases Research Laboratory using the rest of
the CSF samples.DNA isolation
DNA was extracted from the CSF using a modification
of the QIAamp DNA Mini kit (QIAGEN Inc., Valencia,
CA, USA) method. All subsequent steps were performed
as outlined in the QIAGEN DNA Mini protocol (for
details, please see http://www.cdc.gov/ncidod/biotech/
strep/pcr.htm) [8].
Reference PCR
Pneumococcal detection was performed using an assay
targeting the lytA gene as previously described by
Carvalho et al. [8]. A conventional sequential multiplex
PCR, which is able to detect a total of 40 serotypes, was
performed using 8 sequential reactions (see http://
www.cdc.gov/ncidod/biotech/strep/pcr.htm for the latest
updates). The primers which were used for this study
were listed in our previous study [9]. Three triplex PCR
assays were performed as previously described to detect
the following: [1] the bacterial pathogens N. meningitidis
(ctrA), H. influenzae (hpd) and S. pneumoniae (lytA)
[10]; [2] the N. meningitidis serogroups A, X and W;
and [3] the N. meningitidis serogroups B, C and Y [11].
Hib was identified by real-time PCR targeting the bcs2
gene [10]. For all PCR assays, a specimen was consid-
ered positive if the Ct value was ≤35 and negative if the
Ct value was >40. If a Ct value was >35 and ≤40, the
specimen was diluted 10-fold and retested to determine
whether PCR inhibitors were present. The specimen was
considered positive if the Ct value of the diluted speci-
men was ≤35, equivocal if the Ct value was 36–40 and
negative if >40. We accepted the reference PCR as the
standard assay and compared the results of the line
probe assay with the reference PCR results [6].
Bacterial meningitis line probe assay
In this study, we used a line probe assay demo-kit
produced by GenID GmbH, Straßberg, Germany,
which is based on multiplex PCR followed by reverse
hybridization using SSOP. A single Mening1 detection
strip can identify universal bacterial 16 s DNA, three
different meningitis-associated pathogens (N. meningiti-
dis, Hib and S. pneumoniae), four serotypes of N. meningi-
tidis, and the S. pneumoniae genes pbp2B and pbp2X
(which are responsible for resistance to beta-lactam antibi-
otics). The Mening2 detection strip can identify universal
bacterial 16 s DNA, S. pneumoniae and 13 different sero-
types of S. pneumoniae (Fig. 1).
Line probe assay procedure
LPA testing was performed following the manufacturer’s
instructions (GenID GmbH, Straßberg, Germany). First,
a multiplex PCR was performed using the Mening1 PN-
Mix or the Mening2-PN-Mix using DNA isolated from a
CSF sample. Following PCR, the respective biotinylated
Fig. 1 Schematic representation of the bacterial meningitis pathogens line probe assay
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with SSOPs for different pathogens and controls immo-
bilized on a nitrocellulose membrane in a distinctive line
format. During the hybridization, the denatured biotin-
labelled amplicons bind to the gene probes attached to
the strips. A highly specific washing procedure ensures
the hybrids survive only if the sequence of the probe is
100% complementary to that of the amplified DNA.
Streptavidin-coupled alkaline phosphatase binds to the
biotinylated hybrids, and the complex is then detected
by a color reaction after the addition of the substrate
NBT/BCIP. Each test kit consists of 12 nitrocellulose
strips coated with the following pathogen gene probes:
Mening1 contains Hib, N. meningitidis, S. pneumoniae
resistance genes, and Mening2 contains S. pneumoniae
serotypes. The kit also contains denaturing reagent
(solution 1), hybridization buffer (solution 2), stringent
wash solution (solution 3), rinse solution (solution 4),
conjugate solution, conjugate buffer (solution 5), sub-
strate (solution 6) and an incubation tray.
Solutions 2 and 3 were pre-warmed to 47 °C, and all
other solutions were pre-warmed to room temperature.
Twenty microliters of solution 1 was added to each well,
then 20 μl of PCR Mening1-PN-mixture was added to
the denaturing reagent for the Mening1 strip or 20 μl of
PCR Mening2-PN-mixture was added for the Mening2
strip. The samples were then mixed well by pipette and
incubated for 5 min at room temperature. Then, 1 μl of
pre-warmed solution 2 was added to each well, and the
strips were transferred with forceps from the tube into
the incubation tray. The strips were completely coveredby liquid with the printed number facing upwards. The
tray was incubated for 30 min at 47 °C in a shaking
water bath. The hybridization buffer was then com-
pletely discarded, and the strips were washed twice for
1 min each with 1 ml of pre-warmed solution 3. Then,
1 ml of solution 3 was added to each strip, and the strip
was incubated for 15 min at 47 °C in the shaking water
bath. Solution 3 was removed by tapping, and the strips
were washed twice for 1 min with 1 ml of solution 4.
Then, 1 ml of solution 5 diluted 1:1000 was added to
each strip, and the strips were incubated for 30 min on a
horizontal shaker at room temperature. The conjugate
was then removed, and each strip was washed 3 times
with 1 ml of solution 4 for 1 min on a horizontal shaker.
Then, 1 ml of solution 6 was added to each strip, and
the strips were incubated up to 10 min, depending on
the intensity of color development. After the control
lines appeared and before the background staining
emerged by washing twice with 1 ml of distilled water
the conjugate reaction was stopped. Then, the strips
were transferred by forceps from the wells to absorbent
paper and were dried protecting from light. After drying,
the strips were placed on a background sheet of white
paper, and the reaction zone was marked with the sup-
plied template.
Statistical analysis
CDC PCR accepted as a reference test and the sensitivity
of Line Probe Assay for each pathogen was calculated
as: true positive LPA result/true LPA positive result +
false negative LPA result. The specificity of LPA for each
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false positive LPA result + true negative LPA result. The
sensitivity and specificity with 95% confidence interval
of LPA for any bacterial pathogen and each pathogen were
calculated using using MedCalc easy to use statistical soft-
ware (https://www.medcalc.org/calc/diagnostic_test.php).
Results
Among 1460 subjects, 841 (57%) met the criteria for
probable bacterial meningitis. The mean age of the sub-
jects was 51 ± 47 months (range,1–212 months), and
550 (65%) subjects were male. Oral or parenteral anti-
biotic treatment prior to lumbar puncture was reported
in a significant proportion of patients [n = 435 (40%)].
CSF cultures were positive for S. pneumoniae, N. menin-
gitidis, and H. influenaze type b in 23, 6, and 2 patients,
respectively.
Line probe assay
Among the 841 probable bacterial meningitis cases, we
were able to perform the line probe assay in 751 (89%)
CSF samples; among these samples 431 (57%) were
negative, 127 (17%) were positive for S. pneumoniae, 53
(7%) were positive for H. influenzae type b, 41 (5%) were
positive for N. meningitidis, 2 were positive for both S.
pneumoniae and H. influenzae type b, and 2 were positive
for both H. influenzae type b and N. meningitidis. A strip
band for universal bacterial 16 s DNA was detected in 95
(13%) CSF samples. We also detected strip bands in 19
CSF samples, 12 of which were for pb2b and pb2x [dis-
played a band for S. pneumoniae (n = 8), 16 s DNA (n = 2),
both H. influenzae type b and N. meningitidis (n = 1) and
was negative (n = 1)], 6 of them were for pb2b [had a band
for S. pneumoniae (n = 5) and H. influenzae type b (n = 1)]
and 1 for pb2x [also had a band 16SDNA (n = 1)].
In the CSF culture-positive cases, the LPA was positive
in 19 of 23 (82%) S. pneumoniae samples, 4 of 6 (67%)
N. meningitidis samples and 2 of 2 (100%) H. influenzae
type b samples.
Comparison of the LPA with the reference PCR
The results of LAP vs. standard PCR are shown in
Table 1. The specificity of the LPA for all tested
samples was 88% (95% CI: 85–91%), using the stand-
ard PCR as a reference. The specificity of LAP for S.
pneumoniae, H. influenzae type b, and N. meningitidis
was 93% (95% CI: 85–91%), 96% (95% CI: 94–98%)
and 99% (95% CI: 97–99%), respectively. The sensitiv-
ity of the LPA for S. pneumoniae, H. influenzae type
b and N. meningitidis combined was 76% (95% CI: 70–
82%), while for each pathogens individually it was 72%
(95% CI:63–79%), 88% (95% CI: 73–95%), and 81% (95%
CI:67–92%) for S. pneumoniae, H. influenzae type b
and N. meningitidis respectively. Of the 3 PCR-positive samples for non-serotype b H. influenzae, both
samples were negative by LPA. Among the 19 samples
with equivocal PCR results (Ct values of 36–40) for
S. pneumoniae lytA, we performed the LPA in 18
samples, 12 of them were negative, five were positive
for S. pneumoniae and one was positive for universal
bacterial 16 s DNA. Among the six samples with
equivocal PCR results for H. influenzae hpd, LPA was
negative for all of four sample we tested. Among the seven
samples with equivocal PCR results for N. meningitidis
ctrA, LPA was negative for both of two sample we tested.
In total, of the 32 samples with equivocal PCR results, we
were able to perform the LPA in 22 samples, 5 of them
(23%) were positive.
S. pneumoniae serotype comparison
Because the LPA was designed to detect only 13 sero-
types of S. pneumoniae, we compared the line probe
assay to standard PCR with respect to these serotypes.
The results from 53 samples tested by LPA were con-
cordant with 41 samples (77%) tested by PCR. The
test positivity of the line probe assay for serotypes 4,
6A/6B, 9 V/9A, 14, 18, 19 F, 23 F, 3, 19A, 1, 5 and
7 F was 100% (2/2), 80% (4/5), 50% (1/2), 100% (4/4),
60% (3/5), 72% (8/11), 100% (6/6), 100% (1/1), 0% (0/4),
70% (7/10), 100% (5/5) and 0 (n = 0), respectively.
N. meningitidis serogroup comparison
The results from 18 samples tested by LPA were con-
cordant with 35 samples (51%) tested by the standard
PCR. The test positivity of the LPA for serogroups A, B,
C and W was 100% (1/1), 38% (9/24), 100% (2/2) and
0% (0/1), respectively.
Discussion
This is the first study to report the performance of the
LPA in the detection of common bacterial pathogens, in-
cluding S. pneumoniae, N. meningitidis and H. influen-
zae type b and their serotypes/serogroups in CSF clinical
samples which were taken from children during a na-
tional surveillance of bacterial meningitis. LAPs are a
group of novel DNA strip-based tests that use nucleic
acid amplification techniques and reverse hybridization
methods for the rapid detection of genes which are
specific for certain groups of bacteria or mutations
associated with drug resistance. In our demo-kit, the
following genes were used for detection: the ctrA
gene for detection of any N. meningitidis serotype,
sacB for N. meningitidis serogroup A, siaD for N. menin-
gitidis serogroup B, siaD for N. meningitidis serogroup C
and synF/G for N. meningitidis serogroup W/Y; the piuA
gene for any S. pneumoniae and cps genes for serotypes of
S. pneumoniae; and the hpd gene for H. influenzae. In this
study, we compared the line probe assay with reference
Table 1 Comparison of the Line Probe Assay with the Reference PCR for bacterial meningitis in CSF samples
LPA results Reference PCR results
(n)
Negative Sp Hib Men Hi lytA Eq hpd Eq ctrA Eq Total
Negative 380 24 1 6 2 12 4 2 431
Sp 30 92 0 0 0 5 0 0 127
Hib 15 3 35 0 0 0 0 0 53
Men 4 2 0 35 0 0 0 0 41
16S DNA 92 2 0 0 0 1 0 0 95
Double banding Sp or Hib 0 0 1 1 0 0 0 0 2
Double banding Hib or Men 1 1 0 0 0 0 0 0 2
Not done 73 7 3 5 1 1 0 0 90
Total 595 131 40 47 3 19 4 2 841
LPA line probe assay, Sp Streptococcus pneumoniae, Hib H. influenzae type b, Men N. meningitidis, Hi non-typeable H. influenzae, lytA Eq equivocal for ltyA, hpd Eq
equivocal for hpd, ctrA Eq equivocal for ctrA
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tion and serotyping of bacterial meningitidis-associated
pathogens [9–12]. This surveillance of bacterial meningitis
represented approximately 60% of the population in
Turkey before the introduction of pneumococcal and
meningococcal conjugate vaccines [13]. PCR is well
known to be a more sensitive method than culture in pa-
tients with previous antibiotic use prior to lumbar punc-
ture In this study, 40% of the patients had a history of oral
or parenteral antibiotic usage before L/P, and only 6% of
these patients displayed CSF culture positivity; these re-
sults underestimate the presence of common bacterial
pathogens and mislead the decisions regarding to which
vaccine should be implemented in a national
immunization program and the potential effectiveness of
the chosen vaccine. In our study, although limited number
of the CSF culture-positive cases were identified (n = 31),
the positivity of the LPA was 83% for S. pneumoniae, 67%
for N. meningitidis, and 100% for H. influenzae type b, re-
spectively, in culture-positive samples. In contrast, when
we compared the LPA results with the CDC reference
PCR, the specificity was 88%. The specificity of LPA for
each pathogens for S. pneumoniae, H. influenzae type b,
and N. meningitidis was 93, 96, and 99%, respectively. The
sensitivity of the line probe assay for all of S. pneumoniae,
H. influenzae type b, and N. meningitidis was 76, and
for each S. pneumoniae, H. influenzae type b, and N.
meningitidis it was 72, 88 and 81%, respectively. The de-
tection of S. pneumoniae, N. meningitidis, and H. influen-
zae type b by LPA was generally acceptable with slightly
lower overall specificity, although it has a comparable spe-
cificity for each pathogens. Overall sensitivity and specifi-
city of LPA for detection of S. pneumoniae is lower than
expected, but LPA has a better sensitivity for detection of
H. influenzae type b and N. meningitidis. The lower sensi-
tivity of LPA detecting S. pneumoniae may be explainedby usage of large number of (n = 10) primer pairs in strip
1. We think that use of a lower number of primer pairs in-
cluding only a conjugate control, the universal bacterial
16S gene, H. influenzae type b, N. meningitidis (any sero-
type), and S. pneumoniae (any serotype) may improve sen-
sitivity of LPA. This modification may eliminate the
double banding for all bacteria and the penicillin-
resistance gene of S. pneumoniae. Secondly, ctrA and hpd
genes which are used for detection of N. meningitidis and
H. influenzae type b, respectively in LPA are also used in
CDC standard PCR. Hence, we achived higher than %95
sensitivity and specificity rate for both pathogen. On the
other hand, for detection of S.pneumoniae, piuA gene was
used in LPA versus lytA gene was used in CDC standard
PCR. Usage of different genes possibily lead to lower sen-
sitivity of LPA for detection of S. pneumoniae. In this
study, we could not assess the antibiotic resistance of
isolates because of the lack of microbiology laboratory in-
frastructure for antibiotic susceptibility tests in many of
the participated hospitals and very low rate of culture
positivity. The LPA also provides us an opportunity to
simultaneously determine the serogroups of N. meningiti-
dis and S. pneumoniae at the same reaction. Among the
N. meningitidis serogroups, the lowest positivity was
achieved for serogroup B (38%) which is the considerable
serogroup in Europe and within our country [13, 14]. For
serogroups A, C, W and Y, we could not make a conclu-
sion because of the low numbers of each serogroup.
For S. pneumoniae serotype determination was possible in
a sufficient number of patients to conclude that the posi-
tivity was 80, 100, 80, 72, 100, 70 and 100% for st6A/6B,
st14, st18, st19F, st23F, st1 and st5, respectively. Unfortu-
nately, the LPA performance was poor for serotype 19A,
which might be due to the insufficient sensitivity of the
probe used for this serotype. The gold-standard serotyping
method for S. pneumoniae is the Quellung reaction which
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colonies with a set of antisera and visualising the bacteria
under a microscope [15]. It is laborious and requires a
complete set of type-specific antisera, and is therefore
mainly performed by reference laboratories. Alternate
serotyping methods have been developed, but few data
formally comparing the performance of these methods to
the gold-standard Quellung reaction, or to each other, are
available. Satzke et al. evaluated the best pneumococcal
serotyping methods for S. pneumoniae carriage studies in
a large international multi-center study [15]. They invasti-
gated 20 pneumococcal serotyping methods including dir-
ect multiplex PCR, culture mPCR, direct mPCR/reverse
line blot, culture restriction fragment length polymorph-
ism, culture mPCR and microarray, culture microarray
and direct microarray. They conclude that most of these
methods were able to detect the dominant serotype in a
sample, but many of them performed poorly in detecting
the minor serotype populations.
A commercially available LPA for the detection of
common bacterial meningitis pathogens does not cur-
rently exist, but several LPAs are commercially offered
to detect drug resistance in Mycobacterium tuberculosis
strains [16, 17]. In addition to detecting M. tuberculosis
and its resistance to drugs, the line probe assay has also
recently been used to detect extended-spectrum beta-
lactamase and KPC carbapenemase genes in Enterobac-
teriacea [18].
Conclusions
The line probe assays have the following advantages:
a) the assays are easy to perform; b) the assays do
not require special equipment, except for a simple
thermal cycler; c) results are obtained within 1 day;
and d) the assays can simultaneously detect 3 com-
mon bacterial pathogens and their serogroups/sero-
types. However the primary limitation of the present
study is the low number of gold standard CSF bac-
terial culture-positive cases included as a result of
antibiotic usage prior to L/P in nearly half of our pa-
tients. Secondly, we compared the demo-kit LPA
with standard PCR, but the genes which were used
to detect the S.pneumoniae serotypes and H. influen-
zae type b and N.meningitidis serogroups in our kit
were different than those used in the standard PCR,
that caused difficulty in making precise conclusions.
However this is the first clinical study evaluating LPA
in national bacterial surveillance, the results of this
study are prosperous. In conclusion, the LPA assay
can be used to detect common meningitis bacterial patho-
gens in CSF samples, but the assay requires further im-
provement, especially in the strip design (including the
probes used).Abbreviations
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